RecruitMe Clinical Trial

The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
A Study of the ReCor Medical Paradise System in Stage II Hypertension (High Blood Pressure)
Sponsor:ReCor Medical, Inc.
Enrolling:Male and Female Patients
Study Length:3 Years
Clinic Visits:10
Age Range:Between 18 and 75 years old
IRB Number:AAAS0371
U.S. Government ID:NCT03614260
Contact: Suzanne Edwards: 212-342-5128 / sme2146@cumc.columbia.edu
Additional Study Information:

RADIANCE II is a randomized, double-blind, sham-controlled, single cohort study designed todemonstrate the effectiveness (how well it works) and safety of the Paradise Renal Denervation System in hypertensive subjects (subjects with high blood pressure).

Do You Qualify?
Is your blood pressure 140/90 or more?YesNo
Previously or currently prescribed antihypertensive therapy?YesNo
Do you have a diagnosis of Type 1 Diabetes?YesNo
Do you work night shift?YesNo
Submit
Cancel
Investigator
Ajay Kirtane, MD, SM
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Suzanne Edwards
Email: sme2146@cumc.columbia.edu
Phone: 212-342-5128